This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Amr K.S., Ezzat W.M., Elhosary Y.A., Hegazy A.E., Fahim H.H., Kamel R.R.: The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma. Gene, 2016; 575: 66–70AmrK.S.EzzatW.M.ElhosaryY.A.HegazyA.E.FahimH.H.KamelR.R.The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinomaGene2016575667010.1016/j.gene.2015.08.03826302751Search in Google Scholar
Anfossi S., Giordano A., Gao H., Cohen E.N., Tin S., Wu Q., Garza R.J., Debeb B.G., Alvarez R.H., Valero V., Hortobagyi G.N., Calin G.A., Ueno N.T., Woodward W.A., Reuben J.M.: High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer. PLoS One, 2014; 9: e83113AnfossiS.GiordanoA.GaoH.CohenE.N.TinS.WuQ.GarzaR.J.DebebB.G.AlvarezR.H.ValeroV.HortobagyiG.N.CalinG.A.UenoN.T.WoodwardW.A.ReubenJ.M.High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancerPLoS One20149e8311310.1371/journal.pone.0083113388540524416156Search in Google Scholar
Antolin S., Calvo L., Blanco-Calvo M., Santiago M.P., Lorenzo-Patiño M.J., Haz-Conde M., Santamarina I., Figueroa A., Antón-Aparicio L.M., Valladares-Ayerbes M.: Circulating miR-200c and miR-141 and outcomes in patients with breast cancer. BMC Cancer, 2015; 15: 297AntolinS.CalvoL.Blanco-CalvoM.SantiagoM.P.Lorenzo-PatiñoM.J.Haz-CondeM.SantamarinaI.FigueroaA.Antón-AparicioL.M.Valladares-AyerbesM.Circulating miR-200c and miR-141 and outcomes in patients with breast cancerBMC Cancer20151529710.1186/s12885-015-1238-5440584325885099Search in Google Scholar
Asaga S., Kuo C., Nguyen T., Terpenning M., Giuliano A.E., Hoon D.S.: Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin. Chem., 2011; 57: 84–91AsagaS.KuoC.NguyenT.TerpenningM.GiulianoA.E.HoonD.S.Direct serum assay for microRNA-21 concentrations in early and advanced breast cancerClin. Chem.201157849110.1373/clinchem.2010.15184521036945Search in Google Scholar
Basati G., Emami Razavi A., Abdi S., Mirzaei A.: Elevated level of microRNA-21 in the serum of patients with colorectal cancer. Med. Oncol., 2014; 31: 205BasatiG.Emami RazaviA.AbdiS.MirzaeiA.Elevated level of microRNA-21 in the serum of patients with colorectal cancerMed. Oncol.20143120510.1007/s12032-014-0205-325178939Search in Google Scholar
Basati G., Razavi A.E., Pakzad I., Malayeri F.A.: Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer. Tumour Biol., 2016; 37: 1781–1788BasatiG.RazaviA.E.PakzadI.MalayeriF.A.Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancerTumour Biol.2016371781178810.1007/s13277-015-3967-026318304Search in Google Scholar
Beckett E.L., Martin C., Choi J.H., King K., Niblett S., Boyd L., Duesing K., Yates Z., Veysey M., Lucock M.: Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarker. BBA Clin., 2015; 4: 45–51BeckettE.L.MartinC.ChoiJ.H.KingK.NiblettS.BoydL.DuesingK.YatesZ.VeyseyM.LucockM.Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarkerBBA Clin.20154455110.1016/j.bbacli.2015.06.006466171326674922Search in Google Scholar
Branch A.D., Rice C.M.: Antisense gets a grip on miR-122 in chimpanzees. Sci. Transl. Med., 2010; 2: 13ps1BranchA.D.RiceC.M.Antisense gets a grip on miR-122 in chimpanzeesSci. Transl. Med.2010213ps110.1126/scitranslmed.300060520371461Search in Google Scholar
Cazzoli R., Buttitta F., Di Nicola M., Malatesta S., Marchetti A., Rom W.N., Pass H.I.: microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J. Thorac. Oncol., 2013; 8: 1156–1162CazzoliR.ButtittaF.Di NicolaM.MalatestaS.MarchettiA.RomW.N.PassH.I.microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancerJ. Thorac. Oncol.201381156116210.1097/JTO.0b013e318299ac32412322223945385Search in Google Scholar
Chen L., Heikkinen L., Wang C., Yang Y., Sun H., Wong G.: Trends in the development of miRNA bioinformatics tools. Brief. Bioinform., 2019; 20: 1836–1852ChenL.HeikkinenL.WangC.YangY.SunH.WongG.Trends in the development of miRNA bioinformatics toolsBrief. Bioinform.2019201836185210.1093/bib/bby054741452429982332Search in Google Scholar
Chen W.Y., Zhao X.J., Yu Z.F., Hu F.L., Liu Y.P., Cui B.B., Dong X.S., Zhao Y.S.: The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Int. J. Clin. Exp. Pathol., 2015; 8: 7092–7101ChenW.Y.ZhaoX.J.YuZ.F.HuF.L.LiuY.P.CuiB.B.DongX.S.ZhaoY.S.The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancerInt. J. Clin. Exp. Pathol.2015870927101Search in Google Scholar
Chen Y., Du M., Wang J., Xing P., Zhang Y., Li F., Lu X.: MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer. Onco-target, 2016; 7: 48432–48442ChenY.DuM.WangJ.XingP.ZhangY.LiF.LuX.MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancerOnco-target20167484324844210.18632/oncotarget.10302521702927374174Search in Google Scholar
Conev N.V., Donev I.S., Konsoulova-Kirova A.A., Chervenkov T.G., Kashlov J.K., Ivanov K.D.: Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients. BioSci. Trends, 2015; 9: 393–401ConevN.V.DonevI.S.Konsoulova-KirovaA.A.ChervenkovT.G.KashlovJ.K.IvanovK.D.Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patientsBioSci. Trends2015939340110.5582/bst.2015.0117026781797Search in Google Scholar
Cui E.H., Li H.J., Hua F., Wang B., Mao W., Feng X.R., Li J.Y., Wang X.: Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy. Acta Pharmacol. Sin., 2013; 34: 309–313CuiE.H.LiH.J.HuaF.WangB.MaoW.FengX.R.LiJ.Y.WangX.Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapyActa Pharmacol. Sin.20133430931310.1038/aps.2012.125401161822983388Search in Google Scholar
Del Vescovo V., Grasso M., Barbareschi M., Denti M.A.: MicroRNAs as lung cancer biomarkers. World J. Clin. Oncol., 2014; 54: 604–620Del VescovoV.GrassoM.BarbareschiM.DentiM.A.MicroRNAs as lung cancer biomarkersWorld J. Clin. Oncol.20145460462010.5306/wjco.v5.i4.604412952625302165Search in Google Scholar
Dou H., Wang Y., Su G., Zhao S.: Decreased plasma let-7c and miR-152 as noninvasive biomarker for non-small-cell lung cancer. Int. J. Clin. Exp. Med., 2015; 8: 9291–9298DouH.WangY.SuG.ZhaoS.Decreased plasma let-7c and miR-152 as noninvasive biomarker for non-small-cell lung cancerInt. J. Clin. Exp. Med.2015892919298Search in Google Scholar
Ebrahimi A., Sadroddiny E.: MicroRNAs in lung diseases: Recent findings and their pathophysiological implications. Pulm. Pharmacol. Ther., 2015; 34: 55–63EbrahimiA.SadroddinyE.MicroRNAs in lung diseases: Recent findings and their pathophysiological implicationsPulm. Pharmacol. Ther.201534556310.1016/j.pupt.2015.08.00726319446Search in Google Scholar
Eichelser C., Flesch-Janys D., Chang-Claude J., Pantel K., Schwarzenbach H.: Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin. Chem., 2013; 59: 1489–1496EichelserC.Flesch-JanysD.Chang-ClaudeJ.PantelK.SchwarzenbachH.Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progressionClin. Chem.2013591489149610.1373/clinchem.2013.20516123748853Search in Google Scholar
Erbes T., Hirschfeld M., Rücker G., Jaeger M., Boas J., Iborra S., Mayer S., Gitsch G., Stickeler E.: Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. BMC Cancer, 2015; 15: 193ErbesT.HirschfeldM.RückerG.JaegerM.BoasJ.IborraS.MayerS.GitschG.StickelerE.Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarkerBMC Cancer20151519310.1186/s12885-015-1190-4438306625886191Search in Google Scholar
Eyking A., Reis H., Frank M., Gerken G., Schmid K.W., Cario E.: MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancer. PLoS One, 2016; 11: e0156871EykingA.ReisH.FrankM.GerkenG.SchmidK.W.CarioE.MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancerPLoS One201611e015687110.1371/journal.pone.0156871489464227271572Search in Google Scholar
Feng C., Xian Q., Liu S.: Micro RNA-518 inhibits gastric cancer cell growth by inducing apoptosis via targeting MDM2. Biomed. Pharmacother., 2018; 97: 1595–1602FengC.XianQ.LiuS.Micro RNA-518 inhibits gastric cancer cell growth by inducing apoptosis via targeting MDM2Biomed. Pharmacother.2018971595160210.1016/j.biopha.2017.11.09129793321Search in Google Scholar
Ferro A., Peleteiro B., Malvezzi M., Bosetti C., Bertuccio P., Levi F., Negri E., La Vecchia C., Lunet N.: Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur. J. Cancer, 2014; 50: 1330–1344FerroA.PeleteiroB.MalvezziM.BosettiC.BertuccioP.LeviF.NegriE.La VecchiaC.LunetN.Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtypeEur. J. Cancer2014501330134410.1016/j.ejca.2014.01.02924650579Search in Google Scholar
Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C.: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998; 391: 806–811FireA.XuS.MontgomeryM.K.KostasS.A.DriverS.E.MelloC.C.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature199839180681110.1038/358889486653Search in Google Scholar
Gao F., Chang J., Wang H., Zhang G.: Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients. Oncol. Rep., 2014; 31: 351–357GaoF.ChangJ.WangH.ZhangG.Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patientsOncol. Rep.20143135135710.3892/or.2013.283024190459Search in Google Scholar
Ge W., Yu D.C., Li Q.G., Chen X., Zhang C.Y., Ding Y.T.: Expression of serum miR-16, let-7f, and miR-21 in patients with hepato-cellular carcinoma and their clinical significances. Clin. Lab., 2014; 60: 427–434GeW.YuD.C.LiQ.G.ChenX.ZhangC.Y.DingY.T.Expression of serum miR-16, let-7f, and miR-21 in patients with hepato-cellular carcinoma and their clinical significancesClin. Lab.201460427434Search in Google Scholar
Geng Q., Fan T., Zhang B., Wang W., Xu Y., Hu H.: Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Respir. Res., 2014; 15: 149GengQ.FanT.ZhangB.WangW.XuY.HuH.Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancerRespir. Res.20141514910.1186/s12931-014-0149-3424844525421010Search in Google Scholar
Ghanbari R., Mosakhani N., Sarhadi V.K., Armengol G., Nouraee N., Mohammadkhani A., Khorrami S., Arefian E., Paryan M., Malekzadeh R., Knuutila S.: Simultaneous underexpression of let-7a-5p and let-7f-5p microRNAs in plasma and stool samples from early stage colorectal carcinoma. Biomark. Cancer, 2015; 7: 39–48GhanbariR.MosakhaniN.SarhadiV.K.ArmengolG.NouraeeN.MohammadkhaniA.KhorramiS.ArefianE.ParyanM.MalekzadehR.KnuutilaS.Simultaneous underexpression of let-7a-5p and let-7f-5p microRNAs in plasma and stool samples from early stage colorectal carcinomaBiomark. Cancer20157394810.4137/BIC.S25252471139126793011Search in Google Scholar
Hale M.D., Hayden J.D., Grabsch H.I.: Tumour-microenvironment interactions: Role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response. Cell Oncol., 2013; 36: 95–112HaleM.D.HaydenJ.D.GrabschH.I.Tumour-microenvironment interactions: Role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy responseCell Oncol.2013369511210.1007/s13402-013-0127-723494412Search in Google Scholar
Hanahan D., Weinberg R.A.: Hallmarks of cancer: The next generation, Cell, 2011; 144: 646–674HanahanD.WeinbergR.A.Hallmarks of cancer: The next generationCell201114464667410.1016/j.cell.2011.02.01321376230Search in Google Scholar
Haseeb A., Makki M.S., Khan N.M., Ahmad I., Haqqi T.M.: Deep sequencing and analyses of miRNAs, isomiRs and miRNA induced silencing complex (miRISC)-associated miRNome in primary human chondrocytes. Sci. Rep., 2017; 7: 15178HaseebA.MakkiM.S.KhanN.M.AhmadI.HaqqiT.M.Deep sequencing and analyses of miRNAs, isomiRs and miRNA induced silencing complex (miRISC)-associated miRNome in primary human chondrocytesSci. Rep.201771517810.1038/s41598-017-15388-4568023829123165Search in Google Scholar
Hayes C.N., Chayama K.: MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma. Int. J. Mol. Sci., 2016; 17: 280HayesC.N.ChayamaK.MicroRNAs as biomarkers for liver disease and hepatocellular carcinomaInt. J. Mol. Sci.20161728010.3390/ijms17030280481314426927063Search in Google Scholar
Heegaard N.H., Schetter A.J., Welsh J.A., Yoneda M., Bowman E.D., Harris C.C.: Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int. J. Cancer, 2012; 130: 1378–1386HeegaardN.H.SchetterA.J.WelshJ.A.YonedaM.BowmanE.D.HarrisC.C.Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancerInt. J. Cancer20121301378138610.1002/ijc.26153325925821544802Search in Google Scholar
Higuchi T., Todaka H., Sugiyama Y., Ono M., Tamaki N., Hatano E., Takezaki Y., Hanazaki K., Miwa T., Lai S., Morisawa K., Tsuda M., Taniguchi T., Sakamoto S.: Suppression of microRNA-7 (miR-7) bio-genesis by nuclear factor 90-nuclear factor 45 complex (NF90-NF45) controls cell proliferation in hepatocellular carcinoma. J. Biol. Chem., 2016; 291: 21074–21084HiguchiT.TodakaH.SugiyamaY.OnoM.TamakiN.HatanoE.TakezakiY.HanazakiK.MiwaT.LaiS.MorisawaK.TsudaM.TaniguchiT.SakamotoS.Suppression of microRNA-7 (miR-7) bio-genesis by nuclear factor 90-nuclear factor 45 complex (NF90-NF45) controls cell proliferation in hepatocellular carcinomaJ. Biol. Chem.2016291210742108410.1074/jbc.M116.748210507651727519414Search in Google Scholar
Hu Z., Chen X., Zhao Y., Tian T., Jin G., Shu Y., Chen Y., Xu L., Zen K., Zhang C., Shen H.: Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol., 2010; 28: 1721–1726HuZ.ChenX.ZhaoY.TianT.JinG.ShuY.ChenY.XuL.ZenK.ZhangC.ShenH.Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancerJ. Clin. Oncol.2010281721172610.1200/JCO.2009.24.934220194856Search in Google Scholar
Hu Z., Dong J., Wang L.E., Ma H., Liu J., Zhao Y., Tang J., Chen X., Dai J., Wei Q., Zhang C., Shen H.: Serum microRNA profiling and breast cancer risk: The use of miR-484/191 as endogenous controls. Carcinogenesis, 2012; 33: 828–834HuZ.DongJ.WangL.E.MaH.LiuJ.ZhaoY.TangJ.ChenX.DaiJ.WeiQ.ZhangC.ShenH.Serum microRNA profiling and breast cancer risk: The use of miR-484/191 as endogenous controlsCarcinogenesis20123382883410.1093/carcin/bgs03022298638Search in Google Scholar
Huang J., Wu J., Li Y., Li X., Yang T., Yang Q., Jiang Y.: Deregulation of serum microRNA expression is associated with cigarette smoking and lung cancer. Biomed. Res. Int., 2014; 2014: 364316HuangJ.WuJ.LiY.LiX.YangT.YangQ.JiangY.Deregulation of serum microRNA expression is associated with cigarette smoking and lung cancerBiomed. Res. Int.2014201436431610.1155/2014/364316421734725386559Search in Google Scholar
Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X.: Plasma micro-RNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer, 2010; 127: 118–126HuangZ.HuangD.NiS.PengZ.ShengW.DuX.Plasma micro-RNAs are promising novel biomarkers for early detection of colorectal cancerInt. J. Cancer201012711812610.1002/ijc.2500719876917Search in Google Scholar
Janevska D., Chaloska-Ivanova V., Janevski V.: Hepatocellular carcinoma: Risk factors, diagnosis and treatment. Open Access Maced. J. Med. Sci., 2015; 3: 732–736JanevskaD.Chaloska-IvanovaV.JanevskiV.Hepatocellular carcinoma: Risk factors, diagnosis and treatmentOpen Access Maced. J. Med. Sci.2015373273610.3889/oamjms.2015.111487791827275318Search in Google Scholar
Jiang L., Li X., Cheng Q., Zhang B.H.: Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening. Tumour Biol., 2015; 36: 7167–7174JiangL.LiX.ChengQ.ZhangB.H.Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screeningTumour Biol.2015367167717410.1007/s13277-015-3446-725894380Search in Google Scholar
Jung E.J., Santarpia L., Kim J., Esteva F.J., Moretti E., Buzdar A.U., Di Leo A., Le X.F., Bast R.C., Jr., Park S.T., Pusztai L., Calin G.A.: Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer, 2012; 118: 2603–2614JungE.J.SantarpiaL.KimJ.EstevaF.J.MorettiE.BuzdarA.U.Di LeoA.LeX.F.BastR.C.Jr.ParkS.T.PusztaiL.CalinG.A.Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patientsCancer20121182603261410.1002/cncr.26565386401922370716Search in Google Scholar
Kim J.O., Gazala S., Razzak R., Guo L., Ghosh S., Roa W.H., Bédard E.L.: Non-small cell lung cancer detection using microRNA expression profiling of bronchoalveolar lavage fluid and sputum. Anticancer Res., 2015; 35: 1873–1880KimJ.O.GazalaS.RazzakR.GuoL.GhoshS.RoaW.H.BédardE.L.Non-small cell lung cancer detection using microRNA expression profiling of bronchoalveolar lavage fluid and sputumAnticancer Res.20153518731880Search in Google Scholar
Kim S.Y., Jeon T.Y., Choi C.I., Kim D.H., Kim D.H., Kim G.H., Ryu D.Y., Lee B.E., Kim H.H.: Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer. J. Mol. Diagn, 2013; 15: 661–669KimS.Y.JeonT.Y.ChoiC.I.KimD.H.KimD.H.KimG.H.RyuD.Y.LeeB.E.KimH.H.Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancerJ. Mol. Diagn20131566166910.1016/j.jmoldx.2013.04.00423806809Search in Google Scholar
Kodahl A.R., Lyng M.B., Binder H., Cold S., Gravgaard K., Knoop A.S., Ditzel H.J.: Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study. Mol. Oncol., 2014; 8: 874–883KodahlA.R.LyngM.B.BinderH.ColdS.GravgaardK.KnoopA.S.DitzelH.J.Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control studyMol. Oncol.2014887488310.1016/j.molonc.2014.03.002552852924694649Search in Google Scholar
Koga Y., Yamazaki N., Yamamoto Y., Yamamoto S., Saito N., Kakugawa Y., Otake Y., Matsumoto M., Matsumura Y.: Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test. Cancer Epidemiol. Biomarkers Prev., 2013; 22: 1844–1852KogaY.YamazakiN.YamamotoY.YamamotoS.SaitoN.KakugawaY.OtakeY.MatsumotoM.MatsumuraY.Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood testCancer Epidemiol. Biomarkers Prev.2013221844185210.1158/1055-9965.EPI-13-051223950216Search in Google Scholar
Kogo R., Mimori K., Tanaka F., Komune S., Mori M.: Clinical significance of miR-146a in gastric cancer cases. Clin. Cancer Res., 2011; 17: 4277–4284KogoR.MimoriK.TanakaF.KomuneS.MoriM.Clinical significance of miR-146a in gastric cancer casesClin. Cancer Res.2011174277428410.1158/1078-0432.CCR-10-286621632853Search in Google Scholar
Kumar S., Keerthana R., Pazhanimuthu A., Perumal P.: Over-expression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients. Indian J. Biochem. Biophys., 2013; 50: 210–214KumarS.KeerthanaR.PazhanimuthuA.PerumalP.Over-expression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patientsIndian J. Biochem. Biophys.201350210214Search in Google Scholar
Larrea E., Sole C., Manterola L., Goicoechea I., Armesto M., Arestin M., Caffarel M.M., Araujo A.M., Araiz M., Fernandez-Mercado M., Lawrie C.H.: New concepts in cancer biomarkers: Circulating miRNAs in liquid biopsies. Int. J. Mol. Sci, 2016; 17: 627LarreaE.SoleC.ManterolaL.GoicoecheaI.ArmestoM.ArestinM.CaffarelM.M.AraujoA.M.AraizM.Fernandez-MercadoM.LawrieC.H.New concepts in cancer biomarkers: Circulating miRNAs in liquid biopsiesInt. J. Mol. Sci20161762710.3390/ijms17050627488145327128908Search in Google Scholar
Le H.B., Zhu W.Y., Chen D.D., He J.Y., Huang Y.Y., Liu X.G., Zhang Y.K.: Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med. Oncol., 2012; 29: 3190–3197LeH.B.ZhuW.Y.ChenD.D.HeJ.Y.HuangY.Y.LiuX.G.ZhangY.K.Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patientsMed. Oncol.2012293190319710.1007/s12032-012-0303-z22782668Search in Google Scholar
Li J., Liu Y., Wang C., Deng T., Liang H., Wang Y., Huang D., Fan Q., Wang X., Ning T., Liu R., Zhang C.Y., Zen K., Chen X., Ba Y.: Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma. Sci. Rep., 2015; 5: 12921LiJ.LiuY.WangC.DengT.LiangH.WangY.HuangD.FanQ.WangX.NingT.LiuR.ZhangC.Y.ZenK.ChenX.BaY.Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinomaSci. Rep.201551292110.1038/srep12921452822926250939Search in Google Scholar
Li X.X., Gao S.Y., Wang P.Y., Zhou X., Li Y.J., Yu Y., Yan Y.F., Zhang H.H., Lv C.J., Zhou H.H., Xie S.Y.: Reduced expression levels of let-7c in human breast cancer patients. Oncol. Lett., 2015; 9: 1207–1212LiX.X.GaoS.Y.WangP.Y.ZhouX.LiY.J.YuY.YanY.F.ZhangH.H.LvC.J.ZhouH.H.XieS.Y.Reduced expression levels of let-7c in human breast cancer patientsOncol. Lett.201591207121210.3892/ol.2015.2877431506825663883Search in Google Scholar
Lin Q., Chen T., Lin Q., Lin G., Lin J., Chen G., Guo L.: Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer. J. Surg. Oncol., 2013; 107: 767–771LinQ.ChenT.LinQ.LinG.LinJ.ChenG.GuoL.Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancerJ. Surg. Oncol.201310776777110.1002/jso.2331223609137Search in Google Scholar
Liu F., Wang X., Li J., Gu K., Lv L., Zhang S., Che D., Cao J., Jin S., Yu Y.: miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer. Cell Prolif., 2015; 48: 582–592LiuF.WangX.LiJ.GuK.LvL.ZhangS.CheD.CaoJ.JinS.YuY.miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancerCell Prolif.20154858259210.1111/cpr.12201649634426250586Search in Google Scholar
Liu J., Mao Q., Liu Y., Hao X., Zhang S., Zhang J.: Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin. J. Cancer Res., 2013; 25: 46–54LiuJ.MaoQ.LiuY.HaoX.ZhangS.ZhangJ.Analysis of miR-205 and miR-155 expression in the blood of breast cancer patientsChin. J. Cancer Res.2013254654Search in Google Scholar
Liu W.J., Xu Q., Sun L.P., Dong Q.G., He C.Y., Yuan Y.: Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease. Tumour Biol., 2015; 36: 3337–3343LiuW.J.XuQ.SunL.P.DongQ.G.HeC.Y.YuanY.Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous diseaseTumour Biol.2015363337334310.1007/s13277-014-2967-925549793Search in Google Scholar
Liu X., Feng J., Tang L., Liao L., Xu Q., Zhu S.: The regulation and function of miR-21-FOXO3a-miR-34b/c signaling in breast cancer. Int. J. Mol. Sci., 2015; 16: 3148–3162LiuX.FengJ.TangL.LiaoL.XuQ.ZhuS.The regulation and function of miR-21-FOXO3a-miR-34b/c signaling in breast cancerInt. J. Mol. Sci.2015163148316210.3390/ijms16023148434688525647415Search in Google Scholar
Liu X.G., Zhu W.Y., Huang Y.Y., Ma L.N., Zhou S.Q., Wang Y.K., Zeng F., Zhou J.H., Zhang Y.K.: High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med. Oncol., 2012; 29: 618–626LiuX.G.ZhuW.Y.HuangY.Y.MaL.N.ZhouS.Q.WangY.K.ZengF.ZhouJ.H.ZhangY.K.High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancerMed. Oncol.20122961862610.1007/s12032-011-9923-y21516486Search in Google Scholar
Lu J., Zhan Y., Feng J., Luo J., Fan S.: MicroRNAs associated with therapy of non-small cell lung cancer. Int. J. Biol. Sci., 2018; 14: 390–397LuJ.ZhanY.FengJ.LuoJ.FanS.MicroRNAs associated with therapy of non-small cell lung cancerInt. J. Biol. Sci.20181439039710.7150/ijbs.22243593047129725260Search in Google Scholar
Ma G.J., Gu R.M., Zhu M., Wen X., Li J.T., Zhang Y.Y., Zhang X.M., Chen S.Q.: Plasma post-operative miR-21 expression in the prognosis of gastric cancers. Asian Pac. J. Cancer Prev., 2013; 14: 7551–7554MaG.J.GuR.M.ZhuM.WenX.LiJ.T.ZhangY.Y.ZhangX.M.ChenS.Q.Plasma post-operative miR-21 expression in the prognosis of gastric cancersAsian Pac. J. Cancer Prev.2013147551755410.7314/APJCP.2013.14.12.755124460332Search in Google Scholar
Mar-Aguilar F., Mendoza-Ramirez J.A., Malagón-Santiago I., Espino-Silva P.K., Santuario-Facio S.K., Ruiz-Flores P., Rodriguez-Padilla C., Reséndez-Pérez D.: Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis. Markers, 2013; 34: 163–169Mar-AguilarF.Mendoza-RamirezJ.A.Malagón-SantiagoI.Espino-SilvaP.K.Santuario-FacioS.K.Ruiz-FloresP.Rodriguez-PadillaC.Reséndez-PérezD.Serum circulating microRNA profiling for identification of potential breast cancer biomarkersDis. Markers20133416316910.1155/2013/259454Search in Google Scholar
Matamala N., Vargas M.T., Gonzalez-Cámpora R., Miñambres R., Arias J.I., Menéndez P., Andrés-León E., Gómez-López G., Yanowsky K., Calvete-Candenas J., Inglada-Pérez L., Martínez-Delgado B., Benítez J.: Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection. Clin. Chem., 2015; 61: 1098–1106MatamalaN.VargasM.T.Gonzalez-CámporaR.MiñambresR.AriasJ.I.MenéndezP.Andrés-LeónE.Gómez-LópezG.YanowskyK.Calvete-CandenasJ.Inglada-PérezL.Martínez-DelgadoB.BenítezJ.Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detectionClin. Chem.2015611098110610.1373/clinchem.2015.23869126056355Search in Google Scholar
Matsumura T., Sugimachi K., Iinuma H., Takahashi Y., Kurashige J., Sawada G., Ueda M., Uchi R., Ueo H., Takano Y., Shinden Y., Eguchi H., Yamamoto H., Doki Y., Mori M. i wsp.: Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br. J. Cancer, 2015; 113: 275–281MatsumuraT.SugimachiK.IinumaH.TakahashiY.KurashigeJ.SawadaG.UedaM.UchiR.UeoH.TakanoY.ShindenY.EguchiH.YamamotoH.DokiY.MoriM.Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancerBr. J. Cancer201511327528110.1038/bjc.2015.201450638726057451Search in Google Scholar
Mazzoccoli G., Colangelo T., Panza A., Rubino R., Tiberio C., Palumbo O., Carella M., Trombetta D., Gentile A., Tavano F., Valvano M.R., Storlazzi C.T., Macchia G., De Cata A., Bisceglia G. i wsp.: Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancer. Oncotarget, 2016; 7: 45444–45461MazzoccoliG.ColangeloT.PanzaA.RubinoR.TiberioC.PalumboO.CarellaM.TrombettaD.GentileA.TavanoF.ValvanoM.R.StorlazziC.T.MacchiaG.De CataA.BiscegliaG.i wsp.Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancerOncotarget20167454444546110.18632/oncotarget.9989521673327323779Search in Google Scholar
Mishra A.K., Yadav P., Mishra A.: A systemic review on staphylococcal scalded skin syndrome (SSSS): A rare and critical disease of neonates. Open Microbiol. J., 2016; 10: 150–159MishraA.K.YadavP.MishraA.A systemic review on staphylococcal scalded skin syndrome (SSSS): A rare and critical disease of neonatesOpen Microbiol. J.20161015015910.2174/1874285801610010150501208027651848Search in Google Scholar
Muhammad N., Bhattacharya S., Steele R., Ray R.B.: Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3. Oncotarget, 2016; 7: 58595–58605MuhammadN.BhattacharyaS.SteeleR.RayR.B.Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3Oncotarget20167585955860510.18632/oncotarget.11193529545627517632Search in Google Scholar
Mullick Chowdhury S., Wang T.Y., Bachawal S., Devulapally R., Choe J.W., Abou Elkacem L., Yakub B.K., Wang D.S., Tian L., Paulmurugan R., Willmann J.K.: Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs. J. Control Release, 2016; 238: 272–280Mullick ChowdhuryS.WangT.Y.BachawalS.DevulapallyR.ChoeJ.W.Abou ElkacemL.YakubB.K.WangD.S.TianL.PaulmuruganR.WillmannJ.K.Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAsJ. Control Release201623827228010.1016/j.jconrel.2016.08.005518560027503707Search in Google Scholar
Napoli C., Lemieux C., Jorgensen R.: Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell, 1990; 2: 279–289NapoliC.LemieuxC.JorgensenR.Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in transPlant Cell1990227928910.2307/3869076Search in Google Scholar
Ogata-Kawata H., Izumiya M., Kurioka D., Honma Y., Yamada Y., Furuta K., Gunji T., Ohta H., Okamoto H., Sonoda H., Watanabe M., Nakagama H., Yokota J., Kohno T., Tsuchiya N.: Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One, 2014; 9: e92921Ogata-KawataH.IzumiyaM.KuriokaD.HonmaY.YamadaY.FurutaK.GunjiT.OhtaH.OkamotoH.SonodaH.WatanabeM.NakagamaH.YokotaJ.KohnoT.TsuchiyaN.Circulating exosomal microRNAs as biomarkers of colon cancerPLoS One20149e9292110.1371/journal.pone.0092921397627524705249Search in Google Scholar
Okabe H., Satoh S., Furukawa Y., Kato T., Hasegawa S., Nakajima Y., Yamaoka Y., Nakamura Y.: Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res., 2003; 63: 3043–3048OkabeH.SatohS.FurukawaY.KatoT.HasegawaS.NakajimaY.YamaokaY.NakamuraY.Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1Cancer Res.20036330433048Search in Google Scholar
Peng Y., Zhang X., Ma Q., Yan R., Qin Y., Zhao Y., Cheng Y., Yang M., Wang Q., Feng X., Huang Y., Huang W., Zhao Z., Wang L., Wei Y. i wsp.: MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU. Cancer Lett., 2017; 385: 117–127PengY.ZhangX.MaQ.YanR.QinY.ZhaoY.ChengY.YangM.WangQ.FengX.HuangY.HuangW.ZhaoZ.WangL.WeiY.MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFUCancer Lett.201738511712710.1016/j.canlet.2016.10.03527810403Search in Google Scholar
Price C., Chen J.: MicroRNAs in cancer biology and therapy: Current status and perspectives. Genes Dis., 2014; 1: 53–63PriceC.ChenJ.MicroRNAs in cancer biology and therapy: Current status and perspectivesGenes Dis.20141536310.1016/j.gendis.2014.06.004424981525473652Search in Google Scholar
Rani S., Gately K., Crown J., O’Byrne K., O’Driscoll L.: Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma. Cancer Biol. Ther., 2013; 14: 1104–1112RaniS.GatelyK.CrownJ.O’ByrneK.O’DriscollL.Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinomaCancer Biol. Ther.2013141104111210.4161/cbt.26370391203324025412Search in Google Scholar
Roth C., Kasimir-Bauer S., Pantel K., Schwarzenbach H.: Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol. Oncol., 2011; 5: 281–291RothC.Kasimir-BauerS.PantelK.SchwarzenbachH.Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancerMol. Oncol.2011528129110.1016/j.molonc.2011.02.002552829221398193Search in Google Scholar
Ru P., Steele R., Hsueh E.C., Ray R.B.: Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivity. Genes Cancer, 2011; 2: 720–727RuP.SteeleR.HsuehE.C.RayR.B.Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivityGenes Cancer2011272072710.1177/1947601911425832321840922207897Search in Google Scholar
Salem O., Erdem N., Jung J., Münstermann E., Wörner A., Wilhelm H., Wiemann S., Körner C.: The highly expressed 5′isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration. BMC Genomics, 2016; 17: 566SalemO.ErdemN.JungJ.MünstermannE.WörnerA.WilhelmH.WiemannS.KörnerC.The highly expressed 5′isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migrationBMC Genomics20161756610.1186/s12864-016-2869-x497769427502506Search in Google Scholar
Sassen S., Miska E.A., Caldas C.: MicroRNA: Implications for cancer. Virchows Arch., 2008; 452: 1–10SassenS.MiskaE.A.CaldasC.MicroRNA: Implications for cancerVirchows Arch.200845211010.1007/s00428-007-0532-2215113118040713Search in Google Scholar
Setoyama T., Ling H., Natsugoe S., Calin G.A.: Non-coding RNAs for medical practice in oncology. Keio J. Med, 2011; 60: 106–113SetoyamaT.LingH.NatsugoeS.CalinG.A.Non-coding RNAs for medical practice in oncologyKeio J. Med20116010611310.2302/kjm.60.10622200634Search in Google Scholar
Shiotani A., Murao T., Kimura Y., Matsumoto H., Kamada T., Kusunoki H., Inoue K., Uedo N., Iishi H., Haruma K.: Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br. J. Cancer, 2013; 109: 2323–2330ShiotaniA.MuraoT.KimuraY.MatsumotoH.KamadaT.KusunokiH.InoueK.UedoN.IishiH.HarumaK.Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancerBr. J. Cancer20131092323233010.1038/bjc.2013.596381733424104965Search in Google Scholar
Shyu Y.C., Lee T.L., Lu M.J., Chen J.R., Chien R.N., Chen H.Y., Lin J.F., Tsou A.P., Chen Y.H., Hsieh C.W., Huang T.S.: miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. J. Transl. Med., 2016; 14: 200ShyuY.C.LeeT.L.LuM.J.ChenJ.R.ChienR.N.ChenH.Y.LinJ.F.TsouA.P.ChenY.H.HsiehC.W.HuangT.S.miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinomaJ. Transl. Med.20161420010.1186/s12967-016-0956-z493056927370270Search in Google Scholar
Silva J., García V., Zaballos Á., Provencio M., Lombardía L., Almonacid L., García J.M., Domínguez G., Peña C., Diaz R., Herrera M., Varela A., Bonilla F.: Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur. Respir. J., 2011; 37: 617–623SilvaJ.GarcíaV.ZaballosÁ.ProvencioM.LombardíaL.AlmonacidL.GarcíaJ.M.DomínguezG.PeñaC.DiazR.HerreraM.VarelaA.BonillaF.Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survivalEur. Respir. J.20113761762310.1183/09031936.0002961020595154Search in Google Scholar
Song X., Xin N., Wang W., Zhao C.: Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis. Oncotarget, 2015; 6: 35579–35588SongX.XinN.WangW.ZhaoC.Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesisOncotarget20156355793558810.18632/oncotarget.5758474212626417932Search in Google Scholar
Stahlhut Espinosa C.E., Slack F.J.: The role of microRNAs in cancer. Yale J. Biol. Med., 2006; 79: 131–140Stahlhut EspinosaC.E.SlackF.J.The role of microRNAs in cancerYale J. Biol. Med.200679131140Search in Google Scholar
Sun Y., Wang M., Lin G., Sun S., Li X., Qi J., Li J.: Serum micro-RNA-155 as a potential biomarker to track disease in breast cancer. PLoS One, 2012; 7: e47003SunY.WangM.LinG.SunS.LiX.QiJ.LiJ.Serum micro-RNA-155 as a potential biomarker to track disease in breast cancerPLoS One20127e4700310.1371/journal.pone.0047003346856523071695Search in Google Scholar
Tagscherer K.E., Fassl A., Sinkovic T., Richter J., Schecher S., Macher-Goeppinger S., Roth W.: MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int., 2016; 16: 42TagschererK.E.FasslA.SinkovicT.RichterJ.SchecherS.Macher-GoeppingerS.RothW.MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygenCancer Cell Int.2016164210.1186/s12935-016-0321-6490146327293381Search in Google Scholar
Telonis A.G., Loher P., Jing Y., Londin E., Rigoutsos I.: Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. Nucleic Acids Res., 2015; 43: 9158–9175TelonisA.G.LoherP.JingY.LondinE.RigoutsosI.Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneityNucleic Acids Res.2015439158917510.1093/nar/gkv922462708426400174Search in Google Scholar
Teplyuk N.M., Mollenhauer B., Gabriely G., Giese A., Kim E., Smolsky M., Kim R.Y., Saria M.G., Pastorino S., Kesari S., Krichevsky A.M.: MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro. Oncol., 2012; 14: 689–700TeplyukN.M.MollenhauerB.GabrielyG.GieseA.KimE.SmolskyM.KimR.Y.SariaM.G.PastorinoS.KesariS.KrichevskyA.M.MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activityNeuro. Oncol.20121468970010.1093/neuonc/nos074336784522492962Search in Google Scholar
Toiyama Y., Takahashi M., Hur K., Nagasaka T., Tanaka K., Inoue Y., Kusunoki M., Boland C.R., Goel A.: Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J. Natl. Cancer Inst., 2013; 105: 849–859ToiyamaY.TakahashiM.HurK.NagasakaT.TanakaK.InoueY.KusunokiM.BolandC.R.GoelA.Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancerJ. Natl. Cancer Inst.201310584985910.1093/jnci/djt101368736923704278Search in Google Scholar
Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A.: Global cancer statistics. 2012. CA Cancer J. Clin., 2015; 65: 87–108TorreL.A.BrayF.SiegelR.L.FerlayJ.Lortet-TieulentJ.JemalA.Global cancer statistics. 2012CA Cancer J. Clin.2015658710810.3322/caac.2126225651787Search in Google Scholar
Tsujiura M., Ichikawa D., Komatsu S., Shiozaki A., Takeshita H., Kosuga T., Konishi H., Morimura R., Deguchi K., Fujiwara H., Okamoto K., Otsuji E.: Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer, 2010; 102: 1174–1179TsujiuraM.IchikawaD.KomatsuS.ShiozakiA.TakeshitaH.KosugaT.KonishiH.MorimuraR.DeguchiK.FujiwaraH.OkamotoK.OtsujiE.Circulating microRNAs in plasma of patients with gastric cancersBr. J. Cancer20101021174117910.1038/sj.bjc.6605608285309720234369Search in Google Scholar
Tsujiura M., Komatsu S., Ichikawa D., Shiozaki A., Konishi H., Takeshita H., Moriumura R., Nagata H., Kawaguchi T., Hirajima S., Arita T., Fujiwara H., Okamoto K., Otsuji E.: Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer, 2015; 18: 271–279TsujiuraM.KomatsuS.IchikawaD.ShiozakiA.KonishiH.TakeshitaH.MoriumuraR.NagataH.KawaguchiT.HirajimaS.AritaT.FujiwaraH.OkamotoK.OtsujiE.Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancerGastric Cancer20151827127910.1007/s10120-014-0363-124626859Search in Google Scholar
Wang F., Hou J., Jin W., Li J., Yue Y., Jin H., Wang X.: Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: A meta-analysis. Molecules, 2014; 19: 6282–6293WangF.HouJ.JinW.LiJ.YueY.JinH.WangX.Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: A meta-analysisMolecules2014196282629310.3390/molecules19056282627098824840899Search in Google Scholar
Wang G., Wang L., Sun S., Wu J., Wang Q.: Quantitative measurement of serum microRNA-21 expression in relation to breast cancer metastasis in Chinese females. Ann. Lab. Med., 2015; 35: 226–232WangG.WangL.SunS.WuJ.WangQ.Quantitative measurement of serum microRNA-21 expression in relation to breast cancer metastasis in Chinese femalesAnn. Lab. Med.20153522623210.3343/alm.2015.35.2.226433017325729725Search in Google Scholar
Wang H., Hou L., Li A., Duan Y., Gao H., Song X.: Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed. Res. Int., 2014; 2014: 864894WangH.HouL.LiA.DuanY.GaoH.SongX.Expression of serum exosomal microRNA-21 in human hepatocellular carcinomaBiomed. Res. Int.2014201486489410.1155/2014/864894405214524963487Search in Google Scholar
Wang H., Wang L., Wu Z., Sun R., Jin H., Ma J., Liu L., Ling R., Yi J., Wang L., Bian J., Chen J., Li N., Yuan S., Yun J.: Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening. Med. Oncol., 2014; 31: 298WangH.WangL.WuZ.SunR.JinH.MaJ.LiuL.LingR.YiJ.WangL.BianJ.ChenJ.LiN.YuanS.YunJ.Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screeningMed. Oncol.20143129810.1007/s12032-014-0298-825367852Search in Google Scholar
Wang L.G., Gu J.: Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol., 2012; 36: e61–e67WangL.G.GuJ.Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasisCancer Epidemiol.201236e61e6710.1016/j.canep.2011.05.00222018950Search in Google Scholar
Wang R.J., Zheng Y.H., Wang P., Zhang J.Z.: Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Int. J. Clin. Exp. Pathol., 2015; 8: 765–771WangR.J.ZhengY.H.WangP.ZhangJ.Z.Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancerInt. J. Clin. Exp. Pathol.20158765771Search in Google Scholar
WHO: Cancer Fact Sheets. https://www.who.int/news-room/fact-sheets/detail/cancer (31.10.2018)WHOCancer Fact Sheetshttps://www.who.int/news-room/fact-sheets/detail/cancer (31.10.2018)Search in Google Scholar
Wu C., Cao Y., He Z., He J., Hu C., Duan H., Jiang J.: Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer. Tohoku J. Exp. Med., 2014; 232: 85–95WuC.CaoY.HeZ.HeJ.HuC.DuanH.JiangJ.Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancerTohoku J. Exp. Med.2014232859510.1620/tjem.232.8524531034Search in Google Scholar
Wu H.H., Lin W.C., Tsai K.W.: Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev. Mol. Med., 2014; 16: e1WuH.H.LinW.C.TsaiK.W.Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markersExpert Rev. Mol. Med.201416e110.1017/erm.2013.16390862724456939Search in Google Scholar
Wu J., Li G., Wang Z., Yao Y., Chen R., Pu X.Y., Wang J.: Circulating microRNA-21 is a potential diagnostic biomarker in gastric cancer. Dis. Markers, 2015; 2015: 435656WuJ.LiG.WangZ.YaoY.ChenR.PuX.Y.WangJ.Circulating microRNA-21 is a potential diagnostic biomarker in gastric cancerDis. Markers2015201543565610.1155/2015/435656443367926063956Search in Google Scholar
Wu Q., Lu Z., Li H., Lu J., Guo L., Ge Q.: Next-generation sequencing of microRNAs for breast cancer detection. J. Biomed. Biotechnol., 2011; 2011: 597145WuQ.LuZ.LiH.LuJ.GuoL.GeQ.Next-generation sequencing of microRNAs for breast cancer detectionJ. Biomed. Biotechnol.2011201159714510.1155/2011/597145311828921716661Search in Google Scholar
Wu Q., Wang C., Lu Z., Guo L., Ge Q.: Analysis of serum genome-wide microRNAs for breast cancer detection. Clin. Chim. Acta, 2012; 413: 1058–1065WuQ.WangC.LuZ.GuoL.GeQ.Analysis of serum genome-wide microRNAs for breast cancer detectionClin. Chim. Acta20124131058106510.1016/j.cca.2012.02.01622387599Search in Google Scholar
Wu X., Somlo G., Yu Y., Palomares M.R., Li A.X., Zhou W., Chow A., Yen Y., Rossi J.J., Gao H., Wang J., Yuan Y.C., Frankel P., Li S., Ashing-Giwa K.T. i wsp.: De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J. Transl. Med., 2012; 10: 42WuX.SomloG.YuY.PalomaresM.R.LiA.X.ZhouW.ChowA.YenY.RossiJ.J.GaoH.WangJ.YuanY.C.FrankelP.LiS.Ashing-GiwaK.T.De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancerJ. Transl. Med.2012104210.1186/1479-5876-10-42334215022400902Search in Google Scholar
Xiao B., Zhu E.D., Li N., Lu D.S., Li W., Li B.S., Zhao Y.L., Mao X.H., Guo G., Yu P.W., Zou Q.M.: Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol. Rep., 2012; 27: 559–566XiaoB.ZhuE.D.LiN.LuD.S.LiW.LiB.S.ZhaoY.L.MaoX.H.GuoG.YuP.W.ZouQ.M.Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosisOncol. Rep.201227559566Search in Google Scholar
Xu L., Li M., Wang M., Yan D., Feng G., An G.: The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer. BMC Cancer, 2014; 14: 714XuL.LiM.WangM.YanD.FengG.AnG.The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancerBMC Cancer20141471410.1186/1471-2407-14-714418138825255814Search in Google Scholar
Yang I.P., Tsai H.L., Huang C.W., Huang M.Y., Hou M.F., Juo S.H., Wang J.Y.: The functional significance of microRNA-29c in patients with colorectal cancer: A potential circulating biomarker for predicting early relapse. PLoS One, 2013; 8: e66842YangI.P.TsaiH.L.HuangC.W.HuangM.Y.HouM.F.JuoS.H.WangJ.Y.The functional significance of microRNA-29c in patients with colorectal cancer: A potential circulating biomarker for predicting early relapsePLoS One20138e6684210.1371/journal.pone.0066842369600323840538Search in Google Scholar
Yang J.S., Li B.J., Lu H.W., Chen Y., Lu C., Zhu R.X., Liu S.H., Yi Q.T., Li J., Song C.H.: Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. Tumour Biol., 2015; 36: 3035–3042YangJ.S.LiB.J.LuH.W.ChenY.LuC.ZhuR.X.LiuS.H.YiQ.T.LiJ.SongC.H.Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screeningTumour Biol.2015363035304210.1007/s13277-014-2938-125501703Search in Google Scholar
Yau T.O., Wu C.W., Dong Y., Tang C.M., Ng S.S., Chan F.K., Sung J.J., Yu J.: microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma. Br. J. Cancer, 2014; 111: 1765–1771YauT.O.WuC.W.DongY.TangC.M.NgS.S.ChanF.K.SungJ.J.YuJ.microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinomaBr. J. Cancer20141111765177110.1038/bjc.2014.484445373625233396Search in Google Scholar
Yau T.O., Wu C.W., Tang C.M., Chen Y., Fang J., Dong Y., Liang Q., Ng S.S., Chan F.K., Sung J.J., Yu J.: MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer. Oncotarget, 2016; 7: 1559–1568YauT.O.WuC.W.TangC.M.ChenY.FangJ.DongY.LiangQ.NgS.S.ChanF.K.SungJ.J.YuJ.MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancerOncotarget201671559156810.18632/oncotarget.6403481148026621842Search in Google Scholar
Yin J., Bai Z., Song J., Yang Y., Wang J., Han W., Zhang J., Meng H., Ma X., Yang Y., Wang T., Li W., Zhang Z.: Differential expression of serum miR-126, miR-141 and miR-21 as novel biomarkers for early detection of liver metastasis in colorectal cancer. Chin. J. Cancer Res., 2014; 26: 95–103YinJ.BaiZ.SongJ.YangY.WangJ.HanW.ZhangJ.MengH.MaX.YangY.WangT.LiW.ZhangZ.Differential expression of serum miR-126, miR-141 and miR-21 as novel biomarkers for early detection of liver metastasis in colorectal cancerChin. J. Cancer Res.20142695103Search in Google Scholar
Yu H., Jiang L., Sun C., Li Guo L., Lin M., Huang J., Zhu L.: Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer. Gene, 2014; 534: 60–65YuH.JiangL.SunC.Li GuoL.LinM.HuangJ.ZhuL.Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancerGene2014534606510.1016/j.gene.2013.10.024Search in Google Scholar
Yuan R., Wang G., Xu Z., Zhao H., Chen H., Han Y., Wang B., Zhou J., Hu H., Guo Z., Shen H., Xue X.: Up-regulated circulating miR-106a by DNA methylation promised a potential diagnostic and prognostic marker for gastric cancer. Anticancer Agents Med. Chem., 2016; 16: 1093–1100YuanR.WangG.XuZ.ZhaoH.ChenH.HanY.WangB.ZhouJ.HuH.GuoZ.ShenH.XueX.Up-regulated circulating miR-106a by DNA methylation promised a potential diagnostic and prognostic marker for gastric cancerAnticancer Agents Med. Chem.2016161093110010.2174/187152061566615071611065726179261Search in Google Scholar
Yuxia M., Zhennan T., Wei Z.: Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J. Cancer Res. Clin. Oncol., 2012; 138: 2045–2050YuxiaM.ZhennanT.WeiZ.Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosisJ. Cancer Res. Clin. Oncol.20121382045205010.1007/s00432-012-1285-022806310Search in Google Scholar
Zang H., Wang W., Fan S.: The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer. Cancer Chemother, Pharmacol., 2017; 79: 227–231ZangH.WangW.FanS.The role of microRNAs in resistance to targeted treatments of non-small cell lung cancerCancer Chemother, Pharmacol.20177922723110.1007/s00280-016-3130-727515517Search in Google Scholar
Zeng Q., Jin C., Chen W., Xia F., Wang Q., Fan F., Du J., Guo Y., Lin C., Yang K., Li J., Peng X., Li X., Cao K.: Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases. Chin. J. Cancer Res., 2014; 26: 711–716ZengQ.JinC.ChenW.XiaF.WangQ.FanF.DuJ.GuoY.LinC.YangK.LiJ.PengX.LiX.CaoK.Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseasesChin. J. Cancer Res.201426711716Search in Google Scholar
Zhang J., Song Y., Zhang C., Zhi X., Fu H., Ma Y., Chen Y., Pan F., Wang K., Ni J., Jin W., He X., Su H., Cui D.: Circulating MiR-16-5p and MiR-19b-3p as two novel potential biomarkers to indicate progression of gastric cancer. Theranostics, 2015; 5: 733–745ZhangJ.SongY.ZhangC.ZhiX.FuH.MaY.ChenY.PanF.WangK.NiJ.JinW.HeX.SuH.CuiD.Circulating MiR-16-5p and MiR-19b-3p as two novel potential biomarkers to indicate progression of gastric cancerTheranostics2015573374510.7150/thno.10305440249725897338Search in Google Scholar
Zhang R., Wang W., Li F., Zhang H., Liu J.: MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers. Med. Oncol., 2014; 31: 243ZhangR.WangW.LiF.ZhangH.LiuJ.MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancersMed. Oncol.20143124310.1007/s12032-014-0243-x25218271Search in Google Scholar
Zhao W., Zhao J.J., Zhang L., Xu Q.F., Zhao Y.M., Shi X.Y., Xu A.G.: Serum miR-21 level: A potential diagnostic and prognostic biomarker for non-small cell lung cancer. Int. J. Clin. Exp. Med., 2015; 8: 14759–14763ZhaoW.ZhaoJ.J.ZhangL.XuQ.F.ZhaoY.M.ShiX.Y.XuA.G.Serum miR-21 level: A potential diagnostic and prognostic biomarker for non-small cell lung cancerInt. J. Clin. Exp. Med.201581475914763Search in Google Scholar
Zheng R., Pan L., Gao J., Ye X., Chen L., Zhang X., Tang W., Zheng W.: Prognostic value of miR-106b expression in breast cancer patients. J. Surg. Res., 2015; 195: 158–165ZhengR.PanL.GaoJ.YeX.ChenL.ZhangX.TangW.ZhengW.Prognostic value of miR-106b expression in breast cancer patientsJ. Surg. Res.201519515816510.1016/j.jss.2014.12.03525619461Search in Google Scholar
Zhu W., He J., Chen D., Zhang B., Xu L., Ma H., Liu X., Zhang Y., Le H.: Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS One, 2014; 9: e87780ZhuW.HeJ.ChenD.ZhangB.XuL.MaH.LiuX.ZhangY.LeH.Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancerPLoS One20149e8778010.1371/journal.pone.0087780392114224523873Search in Google Scholar
Zhuang C., Jiang W., Huang D., Xu L., Yang Q., Zheng L., Wang X., Hu L.: Serum miR-21, miR-26a and miR-101 as potential bio-markers of hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol., 2016; 40: 386–396ZhuangC.JiangW.HuangD.XuL.YangQ.ZhengL.WangX.HuL.Serum miR-21, miR-26a and miR-101 as potential bio-markers of hepatocellular carcinomaClin. Res. Hepatol. Gastroenterol.20164038639610.1016/j.clinre.2015.11.00226669589Search in Google Scholar